Johnson & Johnson likes what it sees in Qualcomm Inc.’s 2net platform.

A J&J subsidiary called LifeScan Inc. plans to use 2net with its diabetes care products, specifically its connected blood glucose meters.

Terms of the deal between the two companies were not disclosed.

“By using Qualcomm Life’s medical-grade 2net solution, physicians will be able to conveniently access … patients’ blood glucose data from Lifescan’s OneTouch Verio Flex blood glucose monitoring system with built-in Bluetooth Smart Technology, which wirelessly sends data to the OneTouch Reveal cloud-based application,” said a statement distributed by Qualcomm (Nasdaq: QCOM). Doctors will be able to view both historical and recent glucose levels.

Qualcomm said the companies plan to deploy 2net to some doctors’ offices in the fall, and expand it globally in 2018.

“The secure, wireless data capture that 2net provides is valuable for clinicians as they seek transformative ways to treat people with diabetes efficiently and effectively across the care continuum,” said Rick Valencia, president of Qualcomm Life, in a prepared statement.

Johnson & Johnson (NYSE: JNJ) is a holding company with more than 230 operating companies.